流感疫苗对老年人肿瘤坏死因子样弱凋亡诱导因子(TWEAK)的影响
研究在2007-2008年流感季招募70岁以上老年人接种标准剂量三价灭活流感疫苗,检测69名参与者接种前及接种后第4周TWEAK、sCD163和毒株特异性抗体滴度。接种后TWEAK均值591.7±290.1 pg/ml显著低于接种前690.6±330.0 pg/ml(p=.003),sCD163无显著差异(p=.71)。作者认为流感疫苗对TWEAK的影响及特异性抗体应答和衰弱状态的作用需进一步研究。
要点
- 接种后TWEAK均值591.7±290.1 pg/ml显著低于接种前690.6±330.0 pg/ml(p=.003)。
- 接种前后sCD163水平无显著差异(p=.71)。
- 针对H1N1疫苗株抗体滴度≥2倍升高与TWEAK更明显下降相关(p=.091)。
核心结论
- 观察性研究结果表明流感疫苗对TWEAK的影响,包括特定疫苗株特异性抗体应答和衰弱状态的作用,需进一步研究。
- 此类研究可能阐明该效应是否在流感疫苗接种的心血管保护作用中发挥作用。
研究设计与样本
- 观察性研究,于2007-2008年流感季招募70岁以上老年人,接种标准剂量三价灭活流感疫苗。
- 采用一套经过验证的标准评估衰弱状态。
- 疫苗接种前和接种后第4周采集血清,在69名参与者中检测TWEAK、可溶性CD163(sCD163)和毒株特异性流感抗体滴度。
- 采用多元回归分析检验流感疫苗对TWEAK和sCD163的影响,并校正年龄、性别和高血压。
主要发现
- 接种后TWEAK均值±标准差为591.7±290.1 pg/ml,显著低于接种前690.6±330.0 pg/ml(p=.003)。
- 接种前后sCD163水平无显著差异(p=.71)。
- 接种后TWEAK水平在男性中显著更高(p=.01),在大学或更高教育水平的参与者中显著更高(p=.044)。
- 接种后TWEAK according to其他人口学特征或既往疾病情况无显著差异。
- 针对H1N1疫苗株抗体滴度2倍或以上升高与TWEAK更明显下降相关,p<.10水平(p=.091)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出这些观察性研究结果需进一步研究,以阐明流感疫苗对TWEAK的影响及特定疫苗株特异性抗体应答和衰弱状态的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza immunization is recommended for older adults annually, and has been reported to have cardiovascular protective effects. TNF-related weak inducer of apoptosis (TWEAK), an inflammatory mediator implicated in the development of cardiovascular diseases, could be a mechanism for such effect. The objective of this study was to evaluate the effect of influenza vaccine on TWEAK levels. Older persons over 70 years of age were recruited during 2007-2008 influenza season and immunized with the standard dose trivalent inactivated influenza vaccine. Frailty was evaluated using a validated set of criteria. Sera were collected immediately before and during the 4th week after vaccination. Pre- and post-vaccination levels of TWEAK, soluble CD163 (sCD163) and strain-specific influenza antibody titers were measured in 69 participants. Multiple regression analyses were employed to examine the effect of influenza vaccine on TWEAK and sCD163, adjusting for age, sex, and hypertension. Post-vaccination TWEAK [mean ± standard deviation (SD) = 591.7 ± 290.1 pg/ml] was significantly lower than pre-vaccination level (690.6 ± 330.0 pg/ml) (p = .003). No significant difference was observed between pre and post-vaccination sCD163 levels (p = .71). Post-vaccination TWEAK levels were significantly higher in men (p = .01) and in participants with college or higher level of education (p = .044). There was no significant difference in post-vaccination TWEAK according to other demographics or pre-existing medical conditions. A 2-fold or greater antibody titer against H1N1 vaccine strain was associated with a more pronounced reduction in TWEAK at the p < .10 level (p = .091). A time by frailty interaction term (p = .091) indicated that the vaccination-induced reduction of TWEAK was greatest among frail individuals. These results of this observational study indicate that the impact of Influenza vaccine on TWEAK, including the role of specific antibody responses of specific vaccine strains and frailty status, warrants further investigation. Such investigation may elucidate whether this effect plays a role in mediating cardiovascular protection of influenza vaccination.
引用
- Keshtkar-Jahromi M, Ouyang M, Keshtkarjahromi M, et al. Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults. Vaccine. 2018. PMID: 29548604. doi:10.1016/j.vaccine.2017.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。